Bagneux, France

Francois Rigenbach


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Francois Rigenbach in Dermatological Science

Introduction

Francois Rigenbach, based in Bagneux, France, has made notable contributions to dermatological science through his innovative research and patent work. As an inventor with a keen interest in improving the efficacy of antifungal treatments, he has developed significant methodologies that enhance the delivery of active ingredients in dermatological compositions.

Latest Patents

Rigenbach holds a patent for the "Use of hydrophilic penetration agents in dermatological compositions." This patent reveals the remarkable discovery that hydrophilic penetration agents traditionally used for transcutaneous delivery can also effectively improve the penetration of antifungal agents through the nails. His formulation includes antifungal agents from the allylamine family, such as terbinafine-HCl and naftifine-HCl, combined with various hydrophilic penetration agents, and a water-alcohol solvent medium that effectively dissolves the antifungal component.

Career Highlights

Francois Rigenbach is affiliated with Novartis AG, a global leader in the pharmaceutical industry, where he has focused on dermatological innovations. His work not only showcases his ingenuity but also highlights the potential for improving patient treatment options in antifungal therapies.

Collaborations

Throughout his career, Rigenbach has collaborated with esteemed colleagues such as Jean-Pierre Laugier and Marie-France Rude. Their partnership in research and development underscores a commitment to advancing dermatological science, leading to impactful innovations that benefit patients around the world.

Conclusion

Francois Rigenbach continues to be a vital player in the field of dermatology, leveraging his expertise to enhance treatment methods for antifungal conditions. His patent exemplifies the intersection of science and innovation, paving the way for more effective therapeutic solutions for patients experiencing nail fungal infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…